Evidence map›Paper›PMID 31137701›Full record

ReviewCells2019

The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling.

Ryan E Hillmer, Brian A Link

Abstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output.Cold Spring Harbor perspectives in biology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Mechanoepigenetics in musculoskeletal disease.Osteoarthritis and cartilage · 2026
    Review
  7. Article
  8. Modulation of the Mechanosensory Matrisome by Serotonergic Signaling.Results and problems in cell differentiation · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. The role of SWI/SNF complexes in digestive system neoplasms.Medical oncology (Northwood, London, England) · 2024
    Review
  16. Article
  17. Article
  18. Cancers · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ryan E HillmerDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. rhillmer@mcw.edu.ORCID 0000-0001-8040-9700
Brian A LinkDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. blink@mcw.edu.

Funding

RPE Signaling in Ocular Health and DiseaseR01EY029267 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI LINK, BRIAN A · 2018 to 2021
$1.8M
NEI NIH HHS R01 EY029267
6 · The paper itself

Abstract

Hippo signaling controls cellular processes that ultimately impact organogenesis and homeostasis. Consequently, disease states including cancer can emerge when signaling is deregulated. The major pathway transducers Yap and Taz require cofactors to impart transcriptional control over target genes. Research into Yap/Taz-mediated epigenetic modifications has revealed their association with chromatin-remodeling complex proteins as a means of altering chromatin structure, therefore affecting accessibility and activity of target genes. Specifically, Yap/Taz have been found to associate with factors of the GAGA, Ncoa6, Mediator, Switch/sucrose nonfermentable (SWI/SNF), and Nucleosome Remodeling and Deacetylase (NuRD) chromatin-remodeling complexes to alter the accessibility of target genes. This review highlights the different mechanisms by which Yap/Taz collaborate with other factors to modify DNA packing at specific loci to either activate or repress target gene transcription.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsChromatin Assembly and DisassemblyDNA-Binding ProteinsDrosophilaDrosophila ProteinsGenes, SwitchHippo Signaling PathwayHistone MethyltransferasesHumansMi-2 Nucleosome Remodeling and Deacetylase ComplexNuclear ProteinsProtein Serine-Threonine KinasesSignal TransductionTrans-ActivatorsAdaptor Proteins, Signal TransducingBANF1 protein, humanbrm protein, DrosophilaCell Cycle ProteinsDNA-Binding ProteinsDrosophila ProteinsHistone MethyltransferasesMi-2 Nucleosome Remodeling and Deacetylase ComplexNuclear ProteinsProtein Serine-Threonine KinasesTrans-ActivatorsTranscriptional Coactivator with PDZ-Binding Motif ProteinsTranscription FactorsTrl protein, DrosophilaWWTR1 protein, humanYAP1 protein, humanYAP-Signaling ProteinsYki protein, DrosophilachromatinepigeneticHippo pathwaytranscription

Identifiers

PMID31137701
PMCPMC6562424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.